Trademark Overview
On Thursday, April 18, 2024, a trademark application was filed for EXIMMIUM with the United States Patent and Trademark Office. The USPTO has given the EXIMMIUM trademark a serial number of 79404774. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, November 25, 2025. This trademark is owned by Eximmium Biotechnologies GmbH. The EXIMMIUM trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Human healthcare services; animal healthcare services; medical services; medical and healthcare services; human hygiene and beauty care; advisory services relating to medical services; medical services in the field of oncology; medical analysis services for the diagnosis of cancer; medical analysis services for cancer diagnosis and prognosis; medical diagnostic services.
Medical and veterinary preparations, namely, pharmaceutical and biological preparations for the treatment of cancer and infectious disease; Pharmaceuticals and natural remedies in the nature of pharmaceutical and biological preparations for the treatment of cancer and infectious disease; biotechnological preparations for the treatment of cancer and infectious disease for medical use; antibodies for medical purposes; diagnostic agents for medical use; diagnostic preparations and materials, namely, diagnostic preparations for medical purposes; diagnostic agents for pharmaceutical use; diagnostic preparations for medical purposes; anti-cancer drugs; Pharmaceutical compounds for treating cancer; pharmaceutical preparations and substances for use in oncology; clinical diagnostic reagents for medical use
Chemical substances, materials and preparations, namely, chemicals for industrial purposes; chemical compositions and materials, namely, chemicals for use in science; chemical components, namely, chemicals for producing a radio-labelled monoclonal antibody for industrial or scientific use; tagged antibodies for scientific purposes for laboratory use; monoclonal antibodies for scientific use; tagged antibodies for scientific use; immunological antibodies for scientific purposes, other than for medical use; monoclonal antibodies for scientific purposes for diagnostic use, other than medical use; antibodies for scientific purposes, other than for medical or veterinary use; diagnostic preparations for scientific purposes; clinical diagnostics, namely, diagnostic reagents for scientific use other than for medical or veterinary use; diagnostic reagents for in-vitro use for scientific use, other than medical use; diagnostic reagents, other than for medical use in kit form, namely, diagnostic ...
Science and technology services, namely, scientific research and development; natural science services, namely, scientific research; medical and pharmacological research services; information on the subject of scientific research in the field of biochemistry and biotechnology; research relating to biotechnology; biotechnology product testing; research and development in the field of biotechnology; research and development in the pharmaceutical and biotechnology fields; research and development services in the field of antibody technology; research and development services in the field of antibodies; scientific research laboratory services relating to the production of monoclonal antibodies; research and development in the field of diagnostic preparations
